Notification of substantial holding
(a) the name of the issuer of the shares, Medistim ASA (ISIN: NO0010159684)
(b)
the date on which the proportion of shares held reached, exceeded or fell below the thresholds set in the Securities Trading Act section 4-3 subsection (1), 2026-11-06
(c) name of the entity subject to the disclosure obligation, including the name of the shareholder, Swedbank Robur Fonder AB Funds: Swedbank Robur Healthcare, Swedbank Robur Småbolagsfond Norden
(d) the number of shares the notification encompasses, Total: 916 045
(e) the subsequent situation with regard to voting rights, including the percentage of the votes and shares of the company held by the entity concerned, Votes (%): 4.99552 Shares (%): 4.99552
(f) what percentage of the votes and shares of the company the entity concerned holds in the form of rights to shares, 0
(g) the circumstance that triggered the disclosure obligation and whether such circumstance applied to the entity concerned himself or to any related party as mentioned in the Securities Trading Act section 2-5, Sell transaction
(h) the chain of controlled undertakings through which the shares or rights are owned, Fund management (i) where the notification concerns rights to shares as mentioned in the Securities Trading Act section 4-3 subsection (4) the notification shall also contain a description of the rights, including information on the date and time that the rights will or can be exercised and the date and time of their expiry. 0
Please contact Mats Frankeus (disclosures@swedbankrobur.se) if you have any questions.
Disclosures Swedbank Robur Fonder AB SE 105 34 Stockholm